These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2417127)

  • 1. Bleomycin and pulmonary toxicity.
    Van Barneveld PW; Mulder NH; Van der Mark TW; Sleijfer DT
    Neth J Med; 1985; 28(11):516-23. PubMed ID: 2417127
    [No Abstract]   [Full Text] [Related]  

  • 2. On the pathogenesis of bleomycin lung toxicity.
    Pozzi E; Zanon P
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):575-8. PubMed ID: 83311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncolytic action and pulmonary toxicity of bleomycin revisited].
    Lauta VM; Palumbo A; Capece Minutolo M
    Clin Ter; 1988 Mar; 124(6):465-82. PubMed ID: 2462476
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary lesion caused by bleomycin. Experimental study].
    San Román Terán C; Navarro Berástegui V
    Rev Clin Esp; 1982 Jun 15-30; 165(5-6):315-9. PubMed ID: 6182589
    [No Abstract]   [Full Text] [Related]  

  • 5. Bleomycin lung damage: the pathology and nature of the lesion.
    Jones AW
    Br J Dis Chest; 1978 Oct; 72(4):321-6. PubMed ID: 83150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary lesions associated with chemotherapy for cancer (author's transl)].
    Shimosato Y; Baba K
    Rinsho Byori; 1974 Aug; 22(Suppl):159-67. PubMed ID: 4139293
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultrastructural study in the pheasant.
    Bedrossian CW; Greenberg SD; Yawn DH; O'Neal RM
    Arch Pathol Lab Med; 1977 May; 101(5):248-54. PubMed ID: 66910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary pathology due to drugs. Experimental and clinical study of pulmonary changes induced by bleomycin].
    Tansini G; Aiolfi S; Bianchi A; Gandola L; Patrini G; Soccini F; Servida E
    G Ital Chemioter; 1978; 25(1):13-40. PubMed ID: 87353
    [No Abstract]   [Full Text] [Related]  

  • 9. Early diagnosis of bleomycin pulmonary toxicity using bronchoalveolar lavage in dogs.
    Fahey PJ; Utell MJ; Mayewski RJ; Wandtke JD; Hyde RW
    Am Rev Respir Dis; 1982 Jul; 126(1):126-30. PubMed ID: 6178329
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bleomycin lung (author's transl)].
    Burkhardt A; Gebbers JO; Höltje WJ
    Dtsch Med Wochenschr; 1977 Feb; 102(8):281-9. PubMed ID: 65249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
    Luisetti M; Peona V; Salmona M; Pagnoni AM; Villani F; Knerich R; Genghini M; Abbà L; Pozzi E
    Int J Clin Pharmacol Res; 1986; 6(2):129-36. PubMed ID: 2424848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pulmonary changes of bleomycin toxicity.
    Horowitz AL; Friedman M; Smith J; Yagoda A; LaMonte C; Watson RC
    Radiology; 1973 Jan; 106(1):65-8. PubMed ID: 4118845
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of exercise on bleomycin-induced pulmonary toxicity in mice.
    Stone DW; Copelan EA; Weisbrode SE; Rozmiarek H
    Cancer Treat Rep; 1986 Sep; 70(9):1067-71. PubMed ID: 2427195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Broncho-alveolar lavage].
    Struhar D; Greif J; Topilsky M
    Harefuah; 1984 Dec; 107(11):321-2. PubMed ID: 6530181
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary fibrosis: pathways are slowly coming into light.
    Cooper JA
    Am J Respir Cell Mol Biol; 2000 May; 22(5):520-3. PubMed ID: 10783121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study of the production and prevention of lung diseases observed during treatment with bleomycin].
    Flandre O; Beaulaton IS; Damon M; Allieu M
    Therapie; 1972; 27(1):67-76. PubMed ID: 4111716
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of curcumin on bleomycin-induced damages in pulmonary functions in rats].
    Zhao CJ; Niu JZ; Wang JF; Zhou G; Tang BH
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1434-8. PubMed ID: 18837350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pathology of various chronic fibrotic lung diseases (with particular regard to clinical cases)].
    Heard BE
    Internist (Berl); 1974 Jul; 15(7):346-52. PubMed ID: 4138072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.